• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊耐(linezolid)利福霉素肠球菌:流行病学特征。

Linezolid-resistant enterococci in Greece: epidemiological characteristics.

机构信息

Department of Microbiology, School of Medicine, University of Patras, Greece.

出版信息

Chemotherapy. 2011;57(3):181-5. doi: 10.1159/000326444. Epub 2011 Apr 6.

DOI:10.1159/000326444
PMID:21474928
Abstract

BACKGROUND

14 linezolid-resistant enterococci (6 Enterococcus faecium and 8 Enterococcus faecalis) collected during 2009 from patients hospitalized in intensive care units of different Greek hospitals were investigated.

METHODS

The mechanism of resistance to linezolid was determined by sequencing analysis of the domain V of 23S rDNA, while the clonal relatedness was defined by pulsed-field gel electrophoresis and multilocus sequence typing.

RESULTS

All linezolid-resistant enterococci carried the G2576T mutation. E. faecium belonged to the international epidemic clones ST16, ST17, ST203 and ST65, while all E. faecalis strains belonged to the ST28 clone.

CONCLUSIONS

The spread of common linezolid-resistant enterococcal clones in intensive care units located in different areas of Greece emphasizes the importance of application of infection control measures to prevent the spread of such strains.

摘要

背景

2009 年从希腊不同医院重症监护病房住院患者中收集到 14 株耐利奈唑胺肠球菌(6 株屎肠球菌和 8 株粪肠球菌)。

方法

通过测序分析 23S rDNA 结构域 V 来确定对利奈唑胺的耐药机制,而通过脉冲场凝胶电泳和多位点序列分型来定义克隆相关关系。

结果

所有耐利奈唑胺肠球菌均携带 G2576T 突变。屎肠球菌属于国际流行克隆 ST16、ST17、ST203 和 ST65,而所有粪肠球菌菌株均属于 ST28 克隆。

结论

耐利奈唑胺肠球菌常见克隆在分布于希腊不同地区的重症监护病房中的传播,强调了应用感染控制措施来防止此类菌株传播的重要性。

相似文献

1
Linezolid-resistant enterococci in Greece: epidemiological characteristics.希腊耐(linezolid)利福霉素肠球菌:流行病学特征。
Chemotherapy. 2011;57(3):181-5. doi: 10.1159/000326444. Epub 2011 Apr 6.
2
Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.重症监护病房中耐(linezolid)利奈唑烷(Enterococcus faecalis)肠球菌和屎肠球菌的多个克隆株的传播。
J Antimicrob Chemother. 2012 Aug;67(8):1819-23. doi: 10.1093/jac/dks146. Epub 2012 Apr 24.
3
Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.中国多中心研究中耐利奈唑胺的肠球菌和科氏葡萄球菌临床分离株:分子流行病学和耐药机制。
Int J Antimicrob Agents. 2013 Oct;42(4):317-21. doi: 10.1016/j.ijantimicag.2013.06.008. Epub 2013 Jul 20.
4
Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage.耐万古霉素屎肠球菌多位点序列分型C1流行谱系中利奈唑胺耐药性的出现。
J Clin Microbiol. 2006 Mar;44(3):1153-5. doi: 10.1128/JCM.44.3.1153-1155.2006.
5
Comparison of testing methods for detection of decreased linezolid susceptibility due to G2576T mutation of the 23S rRNA gene in Enterococcus faecium and Enterococcus faecalis.粪肠球菌和屎肠球菌中因23S rRNA基因G2576T突变导致的利奈唑胺敏感性降低的检测方法比较
J Clin Microbiol. 2006 Mar;44(3):1098-100. doi: 10.1128/JCM.44.3.1098-1100.2006.
6
Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.一家三级护理医院发生耐利奈唑胺粪肠球菌感染的医院感染暴发。
Diagn Microbiol Infect Dis. 2009 Oct;65(2):175-9. doi: 10.1016/j.diagmicrobio.2009.06.010. Epub 2009 Aug 29.
7
Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.从奥地利同一重症监护病房的两名患者中分离出的新型耐利奈唑胺粪肠球菌和屎肠球菌。
Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):751-4. doi: 10.1007/s10096-002-0807-0. Epub 2002 Sep 13.
8
Cluster of linezolid-resistant Enterococcus faecium ST117 in Norwegian hospitals.挪威医院中耐利奈唑胺屎肠球菌ST117菌群
Scand J Infect Dis. 2014 Oct;46(10):712-5. doi: 10.3109/00365548.2014.923107. Epub 2014 Aug 19.
9
Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis.某大学医院中耐万古霉素和利奈唑胺屎肠球菌的定植:分子流行病学及危险因素分析
Int J Antimicrob Agents. 2009 Feb;33(2):137-42. doi: 10.1016/j.ijantimicag.2008.08.017. Epub 2008 Nov 13.
10
Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.2002 年至 2007 年期间希腊临床粪肠球菌和屎肠球菌的抗生素耐药趋势。
J Hosp Infect. 2010 Jul;75(3):225-7. doi: 10.1016/j.jhin.2009.12.007. Epub 2010 Apr 8.

引用本文的文献

1
Linezolid-resistant Enterococcus faecium clinical isolates from Pakistan: a genomic analysis.巴基斯坦耐利奈唑酮屎肠球菌临床分离株:基因组分析。
BMC Microbiol. 2024 Sep 14;24(1):347. doi: 10.1186/s12866-024-03491-2.
2
Clonal distribution of vancomycin-resistant Enterococcus faecium in Turkey and the new singleton ST733.土耳其万古霉素耐药粪肠球菌的克隆分布和新的单峰 ST733 型。
J Clin Lab Anal. 2020 Dec;34(12):e23541. doi: 10.1002/jcla.23541. Epub 2020 Oct 6.
3
First detection of an -positive, linezolid-resistant ST16 from human in Greece.
在希腊首次从人类身上检测到一株阳性、耐利奈唑胺的ST16菌株。
New Microbes New Infect. 2019 Feb 7;29:100515. doi: 10.1016/j.nmni.2019.01.010. eCollection 2019 May.